Researchers at UCLA's Jonsson Comprehensive Cancer Center have discovered that the growth of prostate cancer cells slowed down in men that ate a low-fat diet together with fish oil supplements for four to six weeks before prostate removal compared to men who ate a Western diet high in fat. The...
Recent studies have suggested that C-11 choline positron emission tomography/computerized tomography (PET/CT) scans can be utilized as a staging and potentially therapeutic tool in prostate cancer. The results of three studies, released during a meeting of the North Central Section of the...
The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. The findings were released during a meeting of the North Central Section...
In a study of complication rates following prostate biopsy among Medicare beneficiaries, Johns Hopkins researchers have found a significant rise in serious complications requiring hospitalization. The researchers found that this common outpatient procedure, used to diagnose prostate cancer, was...
Today, at the 2011 European Multidisciplinary Cancer Congress, two new risk indicators for prostate cancer will be revealed. The investigation, led by Dr David Orsted at the Copenhagen University Hospital, Herlev, reveals that men who are diagnosed with benign prostate enlargement have a higher...
According to an investigation reported today at the 2011 European Multidisciplinary Cancer Congress, individuals suffering with bone metastases from advanced prostate cancer have not had many options until recently. Now the first Phase II investigation of an alpha-pharmaceutical in these...
Genetic differences in prostate cells seem to be a root cause of the prostate cancer disparities between African-American men and white men, according to findings presented at the Fourth AACR Conference on The Science of Cancer Health Disparities, held here Sept. 18-21, 2011. Prostate cancer is...
Physicians are now better able to predict a man's recovery of sexual function after prostate cancer treatment, making a conversation between doctor and patient an important part of pre-treatment planning, a Beth Israel Deaconess Medical Center-led research team suggests. A study published in the...
A study published in the Sept. 21 issue of the Journal of the American Medical Association by a Beth Israel Deaconess Medical Center research team, suggests more open discussion between doctor and patient will assist in improving quality of life for prostate cancer survivors. The report shows...
China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, announced that it has received approvals for its prostate cancer FISH detection kit and Topoisomerase 2-alpha ("TOP2A") FISH detection kit from the State Food and...
InSightec Ltd., the global leader in MR-guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate® system for treating uterine fibroids, announced today that 23 patients with organ confined low risk prostate cancer have already been treated with its...
Zytiga (abiraterone acetate), an ingested pill treatment manufactured by J&J, has been found to potentially extend life by up to four months in men with spreading cancer who have already been treated with chemotherapy. However, there are other altervatives if so desired. According to the...
Men with prostate cancer are at higher risk of developing diabetes or diabetes risk factors if they receive androgen deprivation therapy (ADT) to block the production or action of male hormones that can fuel the growth of this cancer. The results of this new study on the second-most common...
Apart from cutaneous malignancies, prostate cancer (CaP) still remains the most common cancer in men. However, the pathophysiology underlying the disease remains poorly understood and no definite behavioral or environmental risk factors have been identified. Genetics is an important, and...
There was a sharp drop in the number of unnecessary prostate cancer hormonal treatments after Medical policy changes reduced reimbursements. However, hormonal therapy for prostate cancer patients who clearly benefited from such therapy continued unaffected, researchers wrote in an article...
In 2008, a group led by Prof. Marcos Tobias-Machado, initiated a research series involving the role of the human epidermal growth factor receptor extracellular domain (HER-2/neu) in patients with prostate cancer. First, in an initial sample of 30 patients, there was found to be a strong...
A type of drug given to men with prostate cancer, called GnRH (gonadotropin-releasing hormone) agonists have been linked to a higher risk of developing diabetes, stroke or heart disease, and thus must have new warnings on their labels, said the US Food and Drug Administration (FDA). An ongoing...
Prostate cancer -- the most common cancer afflicting American men -- may be effectively diagnosed at an early stage without ionizing radiation, using a non-invasive imaging technique known as contrast-enhanced ultrasound (CEUS), according to a report announced late last week at the 25th Annual...
I heard that sex is good for the prostate but masturbation is NOT good for the prostate. I've also heard it the other way around as well and I dont know what to believe
Whats the truth?